Propargyl-Functionalized Macrocycles Prevent Aggregation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing synthetic procedures for phthalocyanine derivatives, such as azaphthalocyanine and naphthalocyanine, face challenges including low yield, difficult purification, and the formation of undesired side products due to interference from harsh reaction conditions, necessitating the development of propargyl-functionalized macrocyclic compounds with improved properties.
Innovation Solution
The synthesis of propargyl-functionalized macrocyclic compounds, including azaphthalocyanine and naphthalocyanine derivatives, which feature multiple propargyl moieties at peripheral or non-peripheral sites, preventing self-association and enabling efficient solubility in solvents, optimal physicochemical properties, and enhanced photo-sensitizability, utilizing methods like Cu(I)-catalyzed azide-alkyne cycloaddition for further modification.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If prior synthetic procedures are used for generating functionalized macrocycles, then the synthesis can be performed with conventional methods, but the yield is low and purification is difficult
Solution Approach 1:
The patent employs modified reaction parameters including specific catalysts (Pd(OAc)2, CuI), controlled temperatures (reflux conditions), and optimized reaction times to achieve high yields of propargyl-functionalized macrocycles while maintaining ease of synthesis through conventional organic chemistry techniques
2Ease of manufacture
If prior synthetic procedures are used for generating functionalized macrocycles, then the synthesis can be performed with conventional methods, but purification is difficult and side products are formed
Solution Approach 1:
The patent converts the potential harm of harsh reaction conditions into benefit by carefully selecting reaction parameters that promote selective formation of desired products while minimizing side reactions, thereby simplifying purification through reduced side product formation
3Stability of the object's composition
If macrocyclic compounds aggregate, then molecular packing may occur, but solubility decreases and photo-sensitizability is reduced
Solution Approach 1:
The patent introduces propargyl functional groups at peripheral and non-peripheral positions of the macrocyclic core, creating steric segments that prevent close molecular packing and aggregation, thereby maintaining high solubility in organic solvents while preserving the intact macrocyclic structure for photo-sensitizing activity
Solution Approach 2:
The patent applies local steric hindrance through propargyl groups at specific positions (peripheral and non-peripheral sites) to prevent aggregation only in regions where it would occur, while leaving the photoactive core intact to maintain photo-sensitizability
4Stability of the object's composition
If macrocyclic compounds aggregate, then molecular packing may occur, but photo-sensitizability is reduced
Solution Approach 1:
The patent introduces propargyl functional groups at peripheral and non-peripheral positions of the macrocyclic core, creating steric segments that prevent close molecular packing and aggregation, thereby maintaining high solubility in organic solvents while preserving the intact macrocyclic structure for photo-sensitizing activity
Solution Approach 2:
The patent applies local steric hindrance through propargyl groups at specific positions (peripheral and non-peripheral sites) to prevent aggregation only in regions where it would occur, while leaving the photoactive core intact to maintain photo-sensitizability
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These compounds provide non-aggregated molecular scaffolds for various applications, offering improved solubility, photo-sensitizing capabilities, and tumor specificity, facilitating the construction of macrocycle derivatives suitable for photodynamic therapy and other research applications.
Implementation Method 1
The compounds can include multiple propargyl moieties at different sites, e.g., peripheral or non-peripheral sites... providing non-aggregated molecular scaffolds
Implementation Method 2
Exemplary compounds include an azaphthalocyanine complex (AzaPc1) and phthalocyanine complexes (Pc2-Pc5)... suitable non-aggregated molecular scaffolds for construction of numerous macrocycle derivatives via different organic transformation methodologies, e.g., Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC)
Data Source
AI summary
Propargyl-functionalized macrocyclic compounds can include non-aggregating compounds having at least one phthalocyanine (Pc), azaphthalocyanine (AzaPc), or naphthalocyanine (Nc) unit. The compounds can be metal-free or metal-complexed. The metal-complexed compounds can include zinc (II), for example. The compounds can include multiple propargyl moieties at different sites, e.g., peripheral or non-peripheral sites, as described herein. Exemplary compounds include an azaphthalocyanine complex (AzaPc1) and phthalocyanine complexes (Pc2-Pc5). The compounds may provide efficient solubility in aqueous and/or organic solvents, optimal physicochemical properties, improved photo-sensitizability, significant tumor specificity, and electron transfer tunability. The compounds can provide suitable non-aggregated molecular scaffolds for construction of numerous macrocycle derivatives via different organic transformation methodologies, e.g., Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC).